We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
NCE Discovery and DARA Biosciences Join Forces to Develop New Therapies
News

NCE Discovery and DARA Biosciences Join Forces to Develop New Therapies

NCE Discovery and DARA Biosciences Join Forces to Develop New Therapies
News

NCE Discovery and DARA Biosciences Join Forces to Develop New Therapies

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "NCE Discovery and DARA Biosciences Join Forces to Develop New Therapies"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

NCE Discovery Ltd. has entered into an agreement with US-based DARA BioSciences Inc. to work together on the development of new drug target molecules.

DARA BioSciences discovers and develops small molecule treatments for metabolic and CNS diseases and, under the terms of the agreement, will have access to NCED's full range of medicinal chemistry expertise, initially to address two specific drug targets.

"This collaboration is another prime example of NCE Discovery's successful operations as a service provider in the US pharmaceutical market," said Chris Sharman, NCED's CEO.

"We welcome the opportunity to work with the team at DARA BioSciences to speed up the discovery and development of important new medicines."

John Didsbury, Chief Scientific Officer at DARA BioSciences, commented: “We are looking forward to working with NCED and believe that the medicinal chemistry capabilities it brings to the collaboration will help tremendously with our development program of potential new therapies."

Advertisement